What to Expect from This Document?
Better known up until a few years ago for its bioseparation and enabling of
manufacturing of biopharmaceuticals expertise, Prometic has during 2017, continued
its transition that has transformed the company into a biopharmaceutical
corporation with two drug discovery platforms focusing on rare and orphan
diseases representing significant and unmet medical needs.